Nanotechnology in the management of prostate cancer

BJU International

Volumn 102, Issue 11, 2008, Pages 1493-1495

  Gommersall, Lyndon ^a   Shergill, Iqbal S ^a,b   Ahmed, Hashim U ^b   Arya, Manit ^b,c   Grange, Philippe ^c   Gill, Inderbir S ^d  

^a Department of Urology ^*  (United Kingdom)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; GADOLINIUM; IMINE; IRON OXIDE; LEUPRORELIN; LEUPRORELIN CONJUGATED POLY(LACTIC CO GLYCOLIC ACID) LIPOSOME MICROSPHERE; NANOPARTICLE; OLIGONUCLEOTIDE; POLYGLACTIN; POLYPROPYLENIMINE; PROSTATE SPECIFIC ANTIGEN; QUANTUM DOT; SINGLE WALLED NANOTUBE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

BIOSENSOR; COLLOID; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; NANODEVICE; NANOMEDICINE; NANOTECHNOLOGY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE C MYC; PATIENT SAFETY; PRIORITY JOURNAL; PROSTATE CANCER;

HUMANS; MALE; NANOTECHNOLOGY; PROSTATIC NEOPLASMS;

EID: 56649123599     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08120.x     Document Type: Note

References (15)

1. Shergill IS, Rao A, Arya M, Patel H, Gill IS. Nanotechnology: potential applications in urology. BJU Int 2006 97 : 219 20
2. Gommersall L, Shergill IS, Ahmed HU et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007 52 : 368 75
3. Pleschberger M, Saerens D, Weigert S et al. An S-layer heavy chain camel antibody fusion protein for generation of a nanopatterned sensing layer to detect the prostate-specific antigen by surface Plasmon resonance technology. Bioconjug Chem 2004 15 : 664 71
4. Shulga OV, Zhou D, Demchenko AV, Stine KJ. Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform. Analyst 2008 133 : 319 22
5. Briman M, Artukovic E, Zhang L, Chia D, Goodglick L, Gruner G. Direct electronic detection of prostate-specific antigen in serum. Small 2007 3 : 758 62
6. Grimm J, Perez JM, Josephson L, Weissleder R. Novel nanosensors for rapid analysis of telomerase activity. Cancer Res 2004 64 : 639 43
7. Winter PM, Caruthers SD, Kassner A et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha (nu) beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003 63 : 5838 43
8. Kaji N, Tokeshi M, Baba Y. Quantum dots for single biomolecule imaging. Anal Sci 2007 23 : 21 4
9. Kommu SS, Andrews RJ, Mah RW. The future role of intelligent probes in detecting and managing prostate cancer. BJU Int 2006 98 : 717 9
10. Harisinghani MG, Barentsz J, Hahn PF et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003 348 : 2491 9
11. Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 2007 52 : 126 32
12. Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005 102 : 11600 5
13. Johannsen M, Gneveckow U, Taymoorian K et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia 2007 23 : 315 23
14. Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005 2 : 194 205
15. Lee D, Lee JT, Sheperd D, Abrahams H. Preliminary use of the Enseal system for sealing of the dorsal venous complex during robotic assisted laparoscopic prostatectomy. 1186, 2005 AUA Meeting 2005: poster